Publisher
Springer Science and Business Media LLC
Subject
Orthopedics and Sports Medicine
Reference33 articles.
1. Aapro M, Abrahamsson PA, Body JJ et al (2008) Guidance on the use of bisphosphonates in solid tumours: Recommendations of an international expert panel. Ann Oncol 19: 420–432
2. Bauss F, Body JJ (2005) Ibandronate in metastatic bone disease: A review of preclinical data. Anticancer Drugs 16: 107–118
3. Berenson JR, Lichtenstein A, Porter L et al (1998) Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. J Clin Oncol 16: 593–602
4. Boissier S, Magnetto S, Frappart L et al (1997) Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices. Cancer Res 57: 3890–3894
5. Boissier S, Ferreras M, Peyruchaud O et al (2000) Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases. Cancer Res 60: 2949–2954